Home / Tag Archives: FDA approval

Tag Archives: FDA approval

When High Triglycerides Become Dangerous: A New Drug May Help Prevent Pancreatitis

Medical illustration showing the pancreas, elevated triglycerides in the bloodstream, a glucose meter, and a person with abdominal pain representing pancreatitis risk in people with diabetes.

People with diabetes often focus on blood sugar, A1C, and cholesterol. However, very high triglyceride levels deserve just as much attention because they can trigger acute pancreatitis, a painful and potentially life-threatening condition. The connection between diabetes, high triglycerides, and pancreatitis is especially important because severe hypertriglyceridemia can develop silently …

Read More »

A Cholesterol Breakthrough for Diabetes? The First Oral PCSK9 Drug Has Arrived

Prescription pill beside a cholesterol-clogged artery illustration representing the first oral PCSK9 inhibitor for lowering LDL cholesterol in people with diabetes.

For many people with diabetes, lowering LDL cholesterol is just as important as controlling blood sugar. However, not everyone reaches their cholesterol goals with statins alone, and injectable PCSK9 inhibitors can be inconvenient or intimidating. Now, a new option has arrived. The FDA has approved the first oral PCSK9 inhibitor, …

Read More »

Farxiga Just Went Generic—Will Lower Prices Finally Change Diabetes Care?

Prescription bottle of generic dapagliflozin (Farxiga) beside a blood glucose meter, stethoscope, heart model, and kidney model representing diabetes, cardiovascular, and kidney care.

For many people living with type 2 diabetes, the biggest challenge is not finding an effective medication. It is being able to afford it. That reality may begin to change now that the U.S. Food and Drug Administration (FDA) has approved the first generic versions of Farxiga (dapagliflozin), potentially making …

Read More »

The First Disease-Modifying Treatment After a Type 1 Diabetes Diagnosis: Why Teplizumab Is Changing the Conversation

Pediatric endocrinologist discussing teplizumab treatment options with a family following a new type 1 diabetes diagnosis.

For decades, treatment after a type 1 diabetes diagnosis focused almost entirely on insulin replacement and blood glucose management. While advances in technology have improved care, clinicians have had few ways to address the autoimmune process driving beta-cell loss. That is beginning to change. With the FDA’s expansion of teplizumab-mzwv …

Read More »